| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c300a4a0e75c91856c018b915f8d0629
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fab9754adbd2eee7751609959d37fce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c828897c79c220ddd0d8b74eae9ede4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc96e6f2017405aa8066b1875cfb4a4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_364f48766c53b58c374aeaf52065faa1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-087 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2010-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674dbd73607e6181afc7329f63bb05f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_220e157496c8a62b5276060d5dbdeaf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450d7737813b88dacc89f487e8de400f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8671cedd9a7205d74d73e13396ba030f |
| publicationDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010128053-A1 |
| titleOfInvention |
Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases |
| abstract |
The present invention relates to the use of a fully human antigen binding fragment of an antibody for the manufacture of a medicament for the treatment or diagnosis of an ocular disease upon topical administration. The invention further relates to a pharmaceutical composition for ocular topical administration for treatment or diagnosis of an ocular disease comprising a fully human binding fragment of an antibody. In particular, the antibody neutralises HSV1 and HSV2. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015197763-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106488931-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11267871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106488931-B |
| priorityDate |
2009-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |